CN104352553A - Medicine with functions of promoting blood circulation to remove blood stasis and regulating immune functions and preparation method - Google Patents

Medicine with functions of promoting blood circulation to remove blood stasis and regulating immune functions and preparation method Download PDF

Info

Publication number
CN104352553A
CN104352553A CN201410723659.XA CN201410723659A CN104352553A CN 104352553 A CN104352553 A CN 104352553A CN 201410723659 A CN201410723659 A CN 201410723659A CN 104352553 A CN104352553 A CN 104352553A
Authority
CN
China
Prior art keywords
medicine
preparation
polysaccharide
blood circulation
blood stasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410723659.XA
Other languages
Chinese (zh)
Inventor
郭霞
刘福岭
杨福国
李志成
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tangshan Yu Yu Biotechnology Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410723659.XA priority Critical patent/CN104352553A/en
Publication of CN104352553A publication Critical patent/CN104352553A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488Pueraria (kudzu)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/19Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicine with functions of promoting blood circulation to remove blood stasis and regulating immune functions and a preparation method. The medicine comprises 25-60wt% of lycium barbarum polysaccharides, 20-55wt% of jujube date polysaccharides and 10-55wt% of pueraria flavones. The preparation method is characterized by firstly extracting lycium barbarum polysaccharides, jujube date polysaccharides and pueraria flavones respectively and preparing the medicine in proportion. The medicine is low in cost, does not have any toxic or side effect, has the functions of promoting blood circulation to remove blood stasis, resisting oxidation, aging and fatigues, benefiting qi and nourishing blood, reducing lipid and glucose, improving anemia, calming the mind and the nerves, protecting the liver to improve eyesight, aiding digestion and relaxing the bowels, and has obvious effects on enhancement and regulation of immunity, resistance to allergy and invigoration of brains. 2-3 granules of the medicine are taken by the adults every day, 1-2 granules each time, and the medicine can be taken for a long term.

Description

The medicine of a kind of blood circulation promoting and blood stasis dispelling, immunity moderation function and preparation method
Technical field:
The present invention relates to a kind of Chinese medicine, particularly the medicine of a kind of blood circulation promoting and blood stasis dispelling, immunity moderation function and preparation method.
Background technology:
At present, people, due to the large impact of climate, diet and operating pressure, are in sub-health state substantially, and hypoimmunity, anemia, fatiguability, easy old and feeble Liver and kidney are uncomfortable, and treatment Western medicine does not have better method at present, cures the symptoms, not the disease.To the many toxic side effects of human body, though short run effect is good, also large to human injury.Some Chinese formulated products is lost basis effect, ignores extensive knowledge and profound scholarship and the elite place of monarch.
Summary of the invention:
Content of the present invention is the deficiency overcoming existing Chinese patent medicine technology, one is provided to have no side effect, improve body mass, blood circulation promoting and blood stasis dispelling, antioxidation, defying age, resisting fatigue, benefiting qi and nourishing blood, the nerves calming, hepatoprotective improving eyesight, regulate the conditioning medicine and preparation method thereof of Liver and kidney, enhancing and immunity moderation.
The object of the present invention is achieved like this: it is by lycium barbarum polysaccharide, red jujube polysaccharide, Radix Puerariae flavone forms, its percentage by weight is: lycium barbarum polysaccharide 25%-60%, red jujube polysaccharide 20%-55%, Radix Puerariae flavone 10%-50%, its technique comprises the following steps, the liquid submerged fermentation processing technology of fungus, comprise lycium barbarum polysaccharide, red jujube polysaccharide and Radix Puerariae flavone, specific as follows: strain → slant culture 10-20 days → shake-flask culture 2-5 days → fermentor cultivation 1-5 days → filter mycelium, refine the mycelium → purification polysaccharide → drying → pulverizing → composite → sterilizing → fill → packaging in culture fluid simultaneously.
Object of the present invention also can realize in the following manner, and drying process is vacuum drying box ozone sterilization, and the ratio of filter liquor and chloroform butanol solution is 4: 1, and lycium barbarum polysaccharide, red jujube polysaccharide, Radix Puerariae flavone granule are 80-100 order.
Advantage of the present invention is: cost is low, without any side effects, can blood circulation promoting and blood stasis dispelling, antioxidation, defying age, resisting fatigue, benefiting qi and nourishing blood, blood fat reducing, blood sugar lowering, improve anemia, the nerves calming, hepatoprotective improving eyesight, aid digestion, logical stool, strengthen and immunity moderation, antiallergic, brain-strengthening all has remarkable result.
Detailed description of the invention:
Embodiment one:
The percentage by weight of various composition is, lycium barbarum polysaccharide 25, red jujube polysaccharide 55, Radix Puerariae flavone 20.Its technique comprises the following steps, and the liquid submerged fermentation processing technology of fungus, comprises lycium barbarum polysaccharide, red jujube polysaccharide and Radix Puerariae flavone, specific as follows:
Strain → slant culture 10-20 days → shake-flask culture 2-5 days → fermentor cultivation 1-5 days → filter mycelium, refine the mycelium → purification polysaccharide → drying → pulverizing → composite → sterilizing → fill → packaging in culture fluid simultaneously.
Object of the present invention also can realize in the following manner, and drying process is vacuum drying box ozone sterilization, and the ratio of filter liquor and chloroform butanol solution is 4: 1, and lycium barbarum polysaccharide, red jujube polysaccharide, Radix Puerariae flavone granule are 80-100 order.
Embodiment two:
The percentage by weight of various composition is, lycium barbarum polysaccharide 60, red jujube polysaccharide 30, Radix Puerariae flavone 10.Its technique comprises the following steps, and the liquid submerged fermentation processing technology of fungus, comprises lycium barbarum polysaccharide, red jujube polysaccharide and Radix Puerariae flavone, specific as follows:
Strain → slant culture 10-20 days → shake-flask culture 2-5 days → fermentor cultivation 1-5 days → filter mycelium, refine the mycelium → purification polysaccharide → drying → pulverizing → composite → sterilizing → fill → packaging in culture fluid simultaneously.
Object of the present invention also can realize in the following manner, and drying process is vacuum drying box ozone sterilization, and the ratio of filter liquor and chloroform butanol solution is 4: 1, and lycium barbarum polysaccharide, red jujube polysaccharide, Radix Puerariae flavone granule are 80-100 order.
Embodiment three:
The percentage by weight of various composition is, lycium barbarum polysaccharide 25, red jujube polysaccharide 20, Radix Puerariae flavone 55.Its technique comprises the following steps, and the liquid submerged fermentation processing technology of fungus, comprises lycium barbarum polysaccharide, red jujube polysaccharide and Radix Puerariae flavone, specific as follows:
Strain → slant culture 10-20 days → shake-flask culture 2-5 days → fermentor cultivation 1-5 days → filter mycelium, refine the mycelium → purification polysaccharide → drying → pulverizing → composite → sterilizing → fill → packaging in culture fluid simultaneously.
Object of the present invention also can realize in the following manner, and drying process is vacuum drying box ozone sterilization, and the ratio of filter liquor and chloroform butanol solution is 4: 1, and lycium barbarum polysaccharide, red jujube polysaccharide, Radix Puerariae flavone granule are 80-100 order.Namely the present invention is realized.

Claims (5)

1. the medicine of a blood circulation promoting and blood stasis dispelling, immunity moderation function and preparation method, it is characterized in that: it is made up of lycium barbarum polysaccharide, red jujube polysaccharide, Radix Puerariae flavone, its percentage by weight is, lycium barbarum polysaccharide 25-60%, red jujube polysaccharide 20-55%, Radix Puerariae flavone 10-50%.
2. the medicine of a kind of blood circulation promoting and blood stasis dispelling, immunity moderation function and preparation method according to claim 1, it is characterized in that: the liquid submerged fermentation processing technology of fungus, comprise lycium barbarum polysaccharide, red jujube polysaccharide and Radix Puerariae flavone, specific as follows: strain → slant culture 10-20 days → shake-flask culture 2-5 days → fermentor cultivation 1-5 days → filter mycelium, to refine the mycelium → purification polysaccharide → drying → pulverizing → composite → sterilizing → fill → packaging in culture fluid simultaneously.
3. the medicine of a kind of blood circulation promoting and blood stasis dispelling according to claim 2, immunity moderation function and preparation method, is characterized in that; Cultivation temperature-6-68 DEG C, culture fluid pH value is at 4-7.5, and described drying process is vacuum drying box ozone sterilization.
4. the medicine of a kind of blood circulation promoting and blood stasis dispelling according to claim 2, immunity moderation function and preparation method, is characterized in that; Lycium barbarum polysaccharide, red jujube polysaccharide, Radix Puerariae flavone granule are 80-100 order.
5. the medicine of a kind of blood circulation promoting and blood stasis dispelling according to claim 2, immunity moderation function and preparation method, is characterized in that; Polyoses content by weight can more than 80%.
CN201410723659.XA 2014-12-04 2014-12-04 Medicine with functions of promoting blood circulation to remove blood stasis and regulating immune functions and preparation method Pending CN104352553A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410723659.XA CN104352553A (en) 2014-12-04 2014-12-04 Medicine with functions of promoting blood circulation to remove blood stasis and regulating immune functions and preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410723659.XA CN104352553A (en) 2014-12-04 2014-12-04 Medicine with functions of promoting blood circulation to remove blood stasis and regulating immune functions and preparation method

Publications (1)

Publication Number Publication Date
CN104352553A true CN104352553A (en) 2015-02-18

Family

ID=52519926

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410723659.XA Pending CN104352553A (en) 2014-12-04 2014-12-04 Medicine with functions of promoting blood circulation to remove blood stasis and regulating immune functions and preparation method

Country Status (1)

Country Link
CN (1) CN104352553A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101491331A (en) * 2008-01-23 2009-07-29 邓喆铭 Natural health beverage and manufacture method thereof
CN102321519A (en) * 2011-09-27 2012-01-18 陕西科技大学 Brewing method of red date medlar healthcare vinegar
CN103725468A (en) * 2013-12-25 2014-04-16 黎志春 Beautifying red wine and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101491331A (en) * 2008-01-23 2009-07-29 邓喆铭 Natural health beverage and manufacture method thereof
CN102321519A (en) * 2011-09-27 2012-01-18 陕西科技大学 Brewing method of red date medlar healthcare vinegar
CN103725468A (en) * 2013-12-25 2014-04-16 黎志春 Beautifying red wine and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
彭游,等。: "葛根黄酮提取与保健功能研究进展", 《食品工业科技》 *

Similar Documents

Publication Publication Date Title
CN103436407B (en) Preparation method of cordyceps sinensis wine
CN102827750A (en) Maca health care liquor for improving organism immunity and sexuality
CN104489836B (en) A kind of rose vinegar beverage and preparation method thereof
CN103653144B (en) Healthcare drink capable of improving immunity and preparation method thereof
CN102277255B (en) Lucid ganoderma-gingko yellow wine as well as preparation method and function thereof
CN106359629B (en) Method for preparing red bean beverage by using red bean paste bean-boiling wastewater
CN101696386A (en) Highland barley monascus healthy wine and brewing method thereof
CN104928140B (en) Compound fermentation type winter-jujube health care wine and production technology thereof
CN101831369A (en) Golden fungus gingko yellow wine, preparation method and efficacy thereof
CN105950327A (en) Formula of alkaline healthcare beer and preparation method
CN105368695B (en) A kind of Poria cocos propolis fermented vinegar and preparation method thereof
CN105685620A (en) Moringa oleifera oral liquid and preparation method thereof
CN104642603A (en) Cistanche green tea beverage
CN105211604A (en) A kind of Chinese herbal medicine milch goat feed
CN104322794A (en) Selenium-rich chrysanthemum health-care tea and making method thereof
CN107467456A (en) A kind of nourshing kidney moistening lung sealwort Chinese angelica root health beverage and preparation method thereof
CN105077426A (en) Compound dendrobium officinale polysaccharide beverage and preparation method thereof
CN104352553A (en) Medicine with functions of promoting blood circulation to remove blood stasis and regulating immune functions and preparation method
CN102250724B (en) Cordyceps and ginkgo yellow wine as well as preparation method and application thereof
CN105663197A (en) Method for extracting total flavonoids of gnaphalium japonicum
CN106212781A (en) A kind of multifunction health-preserving tea and preparation method thereof
CN103463184B (en) Traditional Chinese medicine microecology preparation for treating diarrhea caused by dysbacteriosis
CN108112841A (en) A kind of cordyceps drink and preparation method thereof
CN104352516A (en) Medicine with functions of regulating liver and kidneys and improving immunities and preparation method
CN101028417A (en) Domestic fungus oral liquid

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C41 Transfer of patent application or patent right or utility model
CB03 Change of inventor or designer information

Inventor after: Guo Xia

Inventor before: Guo Xia

Inventor before: Liu Fuling

Inventor before: Yang Fuguo

Inventor before: Li Zhicheng

COR Change of bibliographic data
TA01 Transfer of patent application right

Effective date of registration: 20160120

Address after: 063000, building 401, room 402, Eastern Mansion, No. 152, Jianshe North Road, Tangshan City hi tech Zone, Hebei,

Applicant after: Tangshan Yu Yu Biotechnology Co., Ltd.

Address before: 063000 C, Eastern Mansion, Tangshan City hi tech Development Zone, Hebei, 401

Applicant before: Guo Xia

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20150218